Year: 2025
Stocks making the biggest moves midday: Home Depot, Intel, Viking Therapeutics, Nvidia and more
These are some of the stocks making the biggest moves during midday trading: Viking Therapeutics — Shares tumbled 42% after phase 2 trial results showed Viking’s experimental oral obesity drug had more side effects than expected. About 20% of the patients in the trial quit using the drug due to symptoms such as nausea and […]
Read More
The senior living market can’t keep up with demand as boomers age
A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. Sign up to receive future editions, straight to your inbox. Senior living has […]
Read More
Crypto stocks tumble on Tuesday as investors go into risk-off mode
The Coinbase logo is displayed on a mobile phone screen with stock market percentages in the background. Idrees Abbas | Sopa Images | Lightrocket | Getty Images Crypto stocks suffered on Tuesday as investors fled tech stocks and riskier corners of the market. Among crypto exchanges, Coinbase and eToro fell more than 5% each, while […]
Read More
S&P expects ‘meaningful tariff revenue’ to offset Trump tax bill impact, maintains U.S. credit rating
U.S. President Donald Trump presents a sweeping spending and tax legislation, known as the “One Big Beautiful Bill Act,” after he signed it, at the White House in Washington, D.C., U.S., July 4, 2025. Leah Millis | Reuters S&P Global said it expects “meaningful” federal government revenue from President Donald Trump’s broad tariff policies to […]
Read More
Lutnick says Intel has to give government equity in return for CHIPS Act funds
Commerce Secretary Howard Lutnick said Tuesday that Intel must give the U.S. government an equity stake in the company in return for CHIPS Act funds. “We should get an equity stake for our money,” Lutnick said on CNBC’s “Squawk on the Street” Tuesday. “So we’ll deliver the money, which was already committed under the Biden […]
Read More
Why UBS just raised its gold forecast again as the precious metal hovers near record high
UBS strategists hiked their forecast for 2026 spot gold prices, seeing a continuation of the tailwainds that have powered a string of record highs in the year to date. The bank kept its end of 2025 target at $3,500 per ounce, up from the current spot rate of around $3,340. For next year, it lifted […]
Read More
Robinhood launches NFL and college football prediction markets
The logo of Robinhood Markets is seen at a pop-up event on Wall Street after the company’s initial public offering in New York City on July 29, 2021. Andrew Kelly | Reuters Robinhood announced Tuesday that the online broker is launching new prediction markets for professional and college-level football. Customers will now be able to […]
Read More
Apple reportedly ups iPhone production in India as country’s Russia ties roil White House
Apple has reportedly boosted iPhone production in India as the country faces pressure from the White House over its Russian oil purchases. “We have planned to up the tariffs on India,” Treasury Secretary Scott Bessent told CNBC’s “Squawk Box” on Tuesday. “These are secondary tariffs for buying the sanctioned Russian oil.” Bessent accused India of “profiteering” […]
Read More
Nvidia says it’s evaluating a ‘variety of products’ after report of new AI China chip
The Nvidia booth at the China International Supply Chain Expo in Beijing on July 16, 2025. Florence Lo | Reuters Nvidia said Tuesday that it is evaluating several products following a report that the company is working on a new artificial intelligence chip for China that is more powerful than the currently available H20. The […]
Read More
Viking Therapeutics shares fall more than 30% on disappointing obesity pill trial data
Shares of Viking Therapeutics fell more than 30% in premarket trading Tuesday after the company released mid-stage trial data on its obesity pill that disappointed investors. The results could be a blow to Viking, which was once seen as a hot M&A target as pharmaceutical companies scramble to join the booming market for obesity and […]
Read More